Out of pocket or out of control: A qualitative analysis of healthcare professional stakeholder involvement in pharmaceutical policy change in Ireland.

Health Policy
Gary L O'BrienStephen Byrne

Abstract

Mandatory co-payments attached to prescription medicines on the Irish public health insurance [General Medical Services (GMS)] scheme have undergone multiple iterations since their introduction in October 2010. To date, whilst patients' opinions on said co-payments have been evaluated, the perspectives of community pharmacists and general practitioners (GPs) have not. To explore the involvement and perceptions of community pharmacists and GPs on this pharmaceutical policy change. A qualitative study using purposive sampling alongside snowballing recruitment was used. Nineteen interviews were conducted in a Southern region of Ireland. Data were analysed using the Framework Approach. Three major themes emerged: 1) the withered tax-collecting pharmacist; 2) concerns and prescribing patterns of physicians; and 3) the co-payment system - impact and sustainability. Both community pharmacists and GPs accepted the theoretical concept of a co-payment on the GMS scheme as it prevents moral hazard. However, there were multiple references to the burden that the current method of co-payment collection places on community pharmacists in terms of direct financial loss and reductions in workplace productivity. GPs independently suggested that ...Continue Reading

References

Oct 10, 1991·The New England Journal of Medicine·S B SoumeraiI Choodnovskiy
Mar 10, 2001·JAMA : the Journal of the American Medical Association·R TamblynL Mallet
Jul 18, 2002·Health & Social Care in the Community·Ellen I SchafheutleMarjorie C Weiss
Sep 26, 2002·Social Science & Medicine·W N KasjeF M Haaijer-Ruskamp
Nov 13, 2004·BMJ : British Medical Journal·Hans V Hogerzeil
Jan 18, 2005·Social Science & Medicine·Evan DoranDavid Henry
May 24, 2005·Medical Care·Michael C SokolRobert S Epstein
Jul 5, 2007·JAMA : the Journal of the American Medical Association·Dana P GoldmanYuhui Zheng
Sep 18, 2007·International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care·Allison TongJonathan Craig
Dec 10, 2008·Research in Social & Administrative Pharmacy : RSAP·Ellen I Schafheutle
Jun 6, 2009·Health Affairs·Thomas M SeldenJoel Ruhter
Mar 21, 2012·Journal of the American Board of Family Medicine : JABFM·Martin RolandDavid Colin Thomé
Nov 9, 2012·The International Journal of Pharmacy Practice·Erika Olsson, Sofia Kälvemark Sporrong
Sep 21, 2013·BMC Medical Research Methodology·Nicola K GaleSabi Redwood
Oct 19, 2014·International Journal of Qualitative Studies on Health and Well-being·Virginia Braun, Victoria Clarke
Jul 29, 2015·The International Journal of Health Planning and Management·Elka AtanasovaWim Groot
Sep 12, 2015·The International Journal of Health Planning and Management·Philipp Hafner, Jörg C Mahlich
Dec 24, 2015·Pharmacoepidemiology and Drug Safety·Sarah-Jo SinnottHelen Whelton
Jan 7, 2017·BMC Health Services Research·Camilla Hansen, Despena Andrioti
Aug 19, 2017·European Journal of Clinical Pharmacology·Sarah-Jo SinnottCaitriona Cahir
May 31, 2018·Health Policy·Sara BurkeSteve Thomas
Jul 28, 2019·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Laia MaynouMarc Saez

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.